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Edited by Horst FeldmannAbstract The results presented demonstrate the expression of
pfkfb4 gene in adult testis and in a mouse spermatogonia germ
cell line (GC-1spg). The genomic organization of the human
pfkfb4 gene shows the existence of 14 exons and 13 introns,
spanning 45 kb. A detailed analysis of the 5 0-ﬂanking region
by transient transfection assays with diﬀerent 5 0-deletion pro-
moter constructs in GC-1spg and mouse sertoli cells (TM-4), al-
lows us to deﬁne the minimal promoter unit, containing several
GC-rich and ETF sequences along the ﬁrst 141 nucleotides in-
volved in basal expression. This gene is activated by serum and
chemical hypoxia (CoCl2 treatment) whereas b-estradiol de-
creases its expression.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mammalian spermatozoa obtain energy by oxidation of
monosaccharides through glycolysis and the Krebs cycle,
to maintain motility. In this sense, mature mammalian sper-
matozoa show a great ability to form lactate when incu-
bated in the presence of hexoses [1] but there are great
diﬀerences between species [2]. Fru-2,6-P2 is the most pow-
erful allosteric activator of PFK-1 and inhibitor of FBPase-
1, modulating the glycolytic pathway. The presence of this
metabolite has been reported in bovine spermatozoa at a
concentration similar to other tissues [3]. The synthesis
and degradation of Fru-2,6-P2 is catalyzed by the bifunc-
tional enzyme, 6-phosphofructo-2-kinase/fructose 2,6-bis-
phosphatase (PFK-2). Distinct isoforms of this enzyme
have been identiﬁed in mammalian tissues [4–6], all func-Abbreviations: PFK-2, 6-phosphofructo-2-kinase/fructose-2,6-bisphos-
phatase; tPFK-2, testis PFK-2; uPFK-2, ubiquitous PFK-2; L-PFK-2,
liver PFK-2; HRE, hypoxia-response element; GRE, glucocorticoid-
response element; DHT, dihydrotestosterone; PDB, phorbol 12,13-d-
ibutyrate
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doi:10.1016/j.febslet.2004.11.096tioning as homodimers with an amino-terminal kinase and
a carboxy-terminal bisphosphatase domain. Although the
catalytic core structure is highly conserved among the diﬀer-
ent isozymes, the amino and carboxy termini are the areas
of least homology [7]. A speciﬁc combination of isozymes
can be simultaneously present in a particular tissue accord-
ing to its metabolic needs.
Previously, we cloned a gene speciﬁcally expressed in human
testis [8] that corresponds to the pfkfb4 gene [7] and encodes
the testes PFK-2 isozyme [9,10]. Recently, it has been demon-
strated that pfkfb4 gene has a strong response to hypoxic stim-
ulation [11]. The other isozymes are coded by three additional
genes: pfkfb1 encodes the liver, muscle and fetal isozymes;
pfkfb2 encodes the heart isoform, and pfkfb3 gene encodes
the ubiquitous isozyme expressed in placenta, brain and diﬀer-
ent tumor cells [7].
Herein, we report the genomic organization and promoter
analysis of human pfkfb4 gene. Furthermore, we have devel-
oped a detailed analysis of its promoter sequence by transient
transfection assays with a series of 5 0-deletion promoter con-
structs in GC-1spg (mouse spermatogonia) cells to deﬁne the
region controlling basal promoter activity. Transcriptional
control by serum, CoCl2, phorbol 12,13-dibutyrate (PDB),
b-estradiol and dihydrotestosterone (DHT) has also been
studied.2. Materials and methods
2.1. Cell culture and transfections
TM-4 (mouse Sertoli) cell line was a gift from Dr. Jaume Rev-
ento´s. GC-1spg (mouse spermatogonia) was from ATCC. TM-4
cells were grown in a 1:1 mixture of HamS F12 medium and
Dulbecos modiﬁed Eagles medium (DMEM) supplemented with
1–2 g/l sodium bicarbonate and 15 mM HEPES, 5% horse serum
and 2.5% fetal calf serum (FCS), and incubated in an humidiﬁed
atmosphere of 5% CO2, 95% air at 37 C. GC-1spg cells were
grown in DMEM with 4 mM L-glutamine adjusted to contain
1.5 g/l sodium bicarbonate and 4.5 g/l glucose, and 10% FCS,
and incubated in a humidiﬁed atmosphere of 10% CO2, 90% air,
at 37 C. The various promoter–reporter fusion plasmids (1 lg)
and 60 ng of the pSV40-b-galactosidase control vector (Promega,
Madison, WI) were co-transfected into cells, using Lipofectamine
2000 reagent (Life technologies, Eggernstein, Germany) according
to the manufacturers instructions. Luciferase activities were assayed
as described in [12]. Luciferase values are expressed as luciferase
activity corrected for b-galactosidase activity. Each transfection
was conducted in triplicate and repeated 3–8 times. Data presented
are means ± S.E.blished by Elsevier B.V. All rights reserved.
Fig. 1. Northern blot analysis of pfkfb4 and pfkfb3 genes. Total RNA
isolated from adult brain, testis and immature testis were analysed
using speciﬁc cDNA probes for the pfkfb4 and pfkfb3 genes.
Normalization was performed using 18s rRNA. A representative
experiment of three independent replicates is shown.
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Testis and brain tissue samples from male rats were homogenized
and total RNA was obtained using the isolation kit Ultraspec (Biotecx
Laboratories, Houston, USA). Northern blot was performed as de-
scribed in [8].
2.3. Antibody production
A speciﬁc antibody was generated against testis PFK-2 (tPFK-2) by
subcutaneous immunization of white New Zealand rabbits with tPFK-
2 N-terminal peptide ((NH2)-YSNGRPALHASQRCVM-(COOH))
that was conjugated to keyhole limpet hemocyanin. This peptide com-
prises a unique region of the tPFK-2 (amino acids 19-35) that diﬀers
signiﬁcantly from the corresponding sequence of the other PFK-2 iso-
zymes. This antibody does not recognize the liver or ubiquitous
isoforms that were identiﬁed by an antibody against liver PFK-2
(L-PFK-2) (Santa Cruz, California, USA) and against ubiquitous
PFK-2 (uPFK-2) [13].
2.4. Western blot analysis
Whole testis, GC-1spg and TM-4 cell lines were homogenized in lysis
buﬀer (50 mM Tris–HCl pH: 6.8, SDS 20% and 10% glycerol). Western
blot was performed as described in [14].The membrane was probed
with speciﬁc antibodies against tPFK-2, uPFK-2, L-PFK-2, and
anti-a-tubulin (Sigma). Immunoreactive proteins were then visualized
by developing membranes with a horseradish peroxidase-conjugated
anti-rabbit or anti-mouse IgG antibody (1:5000) followed by incuba-
tion with chemoluminescence (ECL) Western blot reagent (Amersham
Pharmacia Biotech, Uppsala, Sweden).
2.5. Gene structure and promoter analysis
To obtain the pfkfb4 gene structure, the clone HTG12.1 (a positive
clone from a k FIXII genomic library) and the PAC RP5-1034C16
from GenBank (Accession No. AY86551) database were used. Diﬀer-
ent introns and promoter regions were ampliﬁed by PCR. The
TFSEARCH program on the TRANSFAC databases [15] was used
to identify potential cis-acting elements in the 5 0-ﬂanking region of
the pfkfb4 gene. At least three positive clones of independent PCR
ampliﬁcations were completely sequenced at both strands using the
dye terminator cycle sequencing kit (Perkin–Elmer, Norwalk, CT) fol-
lowing the manufacturers instructions. The reaction products were
analysed on a Perkin–Elmer ABI PRISM 377 automated DNA
sequencer.
2.6. Rapid ampliﬁcation of cDNA ends (5 0-RACE)
The transcription initiation site of the human pfkfb4 gene was deter-
mined by 5 0RACE, using the FirstChoice RACE-Ready cDNA kit
(Ambion, Austin, USA) according to the manufacturers instructions.
In brief, from a population of human testis cDNA, which was ampli-
ﬁed only from full-length, capped mRNAs and ligated to a RNA adap-
ter oligonucleotide in their 5 0 end, we performed two rounds of PCR.
The primers used for the initial PCR were 5 0GCTGATGGC-
GATGAATGAACACTG30, which was derived from the adapter,
and gene-speciﬁc primers, 5 0CCTGAAGAAGATCTGGATGCCAT-
AACACGAA3 0 and 5 0GATTGGTGTGCCCACTCGG3 0 which are
located at +33 and +190 in the genomic sequence from the ATG
codon, respectively. In the second round, the primers were
5 0CGCGGATCCGAATTAATACGACTCACTATAGG 3 0 which
was derived from the adapter, and gene-speciﬁc primers: 5 0GAC-
TCATCCCGGCCCCG30 and 5 0GCACGCTTGCCAGCGCGGTG
3 0, positions 3 and +78 from the ATG codon. Cycling conditions
were 94 C for 30 s, 63 C for 30 s and 68 C for 2 min and 30s for
40 cycles. The PCR products were separated in a 2% agarose gel.
Bands were isolated and ligated to a TOPO-TA cloning vector (Invit-
rogen) and sequenced as described above.
2.7. Plasmid constructions
PCR products from promoter region were cloned into the TOPO-
TA cloning vector and subsequently subcloned into the pGL2basic
vector (Promega, Madison, WI). The identities of the clones were con-
ﬁrmed by sequencing. These plasmid constructs were named: pfkfb4/
3587 and pfkfb4/1077. The construct pfkfb4/1800 was generated
by cutting with AﬂII and subcloning a partial fragment of the original
construct pfkfb4/3587. A small construct, pfkfb4/428, was gener-ated by cutting pfkfb4/1077 with MluI and re-ligating the resulting
vector. pfkfb4/428 plasmid construct was cut with MluI + PvuII
and PvuII + HindIII restriction enzymes, fragments of 266 and 166
bp, respectively, were removed obtaining the pfkfb4/166 and the
pfkfb4/428D (166) constructs. All plasmid constructs have been
named according to their complete length, where the ﬁrst 21 nucleo-
tides of the 5 0UTR mRNA sequence from the transcription initiation
site (+1) to the position +21 (4 nucleotides upstream to the ATG co-
don) are contained.3. Results
3.1. Cellular speciﬁcity of pfkfb4 gene expression
In order to study the expression pattern of the pfkfb4 gene,
we measured its mRNA levels in testis at day 5 after birth and
adult tissue. As shown in Fig. 1, Northern blot analysis dem-
onstrated pfkfb4 mRNA only in adult testis, whereas samples
of neonatal testis or brain tissue did not express it. In contrast,
pfkfb3 mRNA was detected in testis at diﬀerent developmental
stages and brain, indicating a constitutive expression of this
ubiquitous gene.
To elucidate whether pfkfb4 and pfkfb3 gene products are
present speciﬁcally in diﬀerent cells, we generated a speciﬁc
antibody against tPFK-2 that comprises a unique region of
the tPFK-2 (amino acids 19–35) that diﬀers notably from the
corresponding sequence of other PFK-2 isozymes. As shown
in Fig. 2A, this antibody does not recognize the hepatic or
ubiquitous isozymes identiﬁed by antibodies against L-PFK-
2 or uPFK-2. tPFK-2 and uPFK-2 isozymes are detected in
adult rat testis. In fact, mouse spermatogonia (GC-1spg) and
mouse Sertoli (TM-4) cells expressed either tPFK-2 or
uPFK-2 isozymes, respectively (Fig. 2B), suggesting that the
two isozymes may be expressed in adult testis in diﬀerent cell
types.
3.2. Genomic organization of the pfkfb4 gene
The genomic sequence of the human testis pfkfb4 gene was
isolated from a kFIXII genomic library using a pfkfb4 cDNA
probe [8]. Three overlapping phage clones were obtained:
HTG-1.1, HTG-3.1 and HTG-12.1, containing 12, 16 and 18
kb, respectively. These clones were analysed by restriction
mapping using NotI, EcoRI and XbaI restriction enzymes
Fig. 2. Expression of PFK-2 isozymes. (A) 30 lg of testis, brain and
liver total proteic extracts were analysed by Western blot using three
diﬀerent speciﬁc antibodies. (B) 30 lg of protein extract from cultured
cell lines (GC-1spg and TM-4) and whole testis extract were analysed
by Western blot using speciﬁc antibodies against tPFK-2 and uPFK-2.
As loading control a speciﬁc antibody against a-tubulin was used. A
representative experiment of three independent replicates is shown.
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Comparison of the genomic pfkfb4 sequence obtained from
HTG12.1 with that of the PAC RP5-1034C16, obtained from
the GenBank database and the pfkfb4 cDNA sequence, al-
lowed us to complete the genomic structure of the pfkfb4 gene
(GenBank Accession No., Bankit 670868). Introns 3, 4, 5, 7, 8,
9, 10, 11, 12 and 13 were successfully ampliﬁed by PCR using
forward and reverse internal primers of the diﬀerent exons.
Partial sequences were assembled using STADENs (1982) pro-
gram [16]. Pfkfb4 gene spans at least 45 kb of genomic DNA
and contains 14 exons and 13 introns (Fig. 3). The size of
exons ranges from 57 bp (exon VI) to 1052 bp (exon XIV),Fig. 3. Structural organization of the human pfkfb4 gene. Description of the e
sequences at exon–intron boundaries are shown. Exon sequences are in ca
schema of human pfkfb4 gene (lower panel). This sequence has been depositand that of the introns ranges from 101 bp to more than 6.4
kb, with introns I, III and IX being the longest and introns
XI and II being the shortest. The intron–exon junctions agree
with the canonical GT/AG rule [17].
3.3. Analysis of the 5 0-ﬂanking region of the pfkfb4 gene
Analysis of the PAC RP5-1034C16 sequence shows that the
5 0-ﬂanking region of pfkfb4 gene would be restricted to the 7.4-
kb fragment between the collagen VII gene and exon I of the
pfkfb4. In order to characterize the transcription start site,
we performed 5 0-RACE using a population of human testis
cDNA which was ampliﬁed only from full-length, capped
mRNAs and ligated to a RNA adapter oligonucleotide (Fig.
4A). We designed two PCRs using two diﬀerent gene speciﬁc
primers, so the resulting PCR products are 100 bp diﬀerent
in length (Fig. 4B). Based on sequencing analysis of PCR prod-
ucts, 12 independent clones showed that the transcription ini-
tiation site corresponds to a C residue in position 25 from the
ATG, hereafter named +1. After cloning and sequencing a
fragment of 3587 nucleotides (pfkfb4/3587) of human pfkfb4
5 0-ﬂanking, this region was analysed for the presence of con-
sensus transcription factor binding sites using the web based
TFSEARCH and Mat Inspector search programs (Fig. 5).
TATA sequences are present at 1257 and 1744 bp from
the transcription start site. G + C rich sequences are present
along the fragment, although are concentrated at the 200
nucleotides closest to the ATG codon, where several Speciﬁc
protein 1 (Sp1), Activator Protein-2 (AP-2) and ETF putative
motifs are also found. In addition, we have found high homol-
ogy consensus sequences for transcription factors relevant in
testis such as hypoxia-response elements (HRE) at positions
400, 492 and 1036 (5 0 CGTGC 3 0), glucocorticoid-
response elements (GRE) at positions 690, 1069, 1605,
1885, 2284, 2730 and 2884 (5 0 AGAACAnnnTGTTCT
3 0). Putative binding sequences for Sox proteins (SRE), which
play important functions in testis development [18], were
found at positions 200, 696, 1280, 1411, (5 0 AA-
CAAAG 3 0). All in all, these motifs might contribute to the
regulation of the pfkfb4 testis gene expression.xon/intron splice junctions. Size of exons and introns are indicated and
pital letters and introns in lowercase letters (upper panel). Structural
ed in the GenBank database under the Accession No. Bankit 670868.
Fig. 4. 5 0RACE from human testis pfkfb4 gene. (A) Schema illustrat-
ing the strategy to 5 0RACE. (B) 2% agarose gel showing the 5 0RACE
INNER PCR using a human testis cDNA library (Ambion, Houston,
USA). Lanes 2 and 3 correspond to the PCR done with the 5 0-RACE
inner primer derived from the adapter and the two especiﬁc pfkfb4
primers, respectively. Lanes 1 and 4 are the negative controls of each
reaction. Lane 5 is the positive control for the 5 0RACE reaction and
lane 6 is its negative control.
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To localize the functional regions of the human pfkfb4 pro-
moter, we generated a series of pGL2 basic-luciferase reporter
constructs that contained deleted fragments of the 5 0-ﬂanking
region of 1800, 1077, 428, 166 nucleotides, respectively, with a
common 3 0-terminus at 4 nucleotides upstream from the ATG
codon (pfkfb4/1800, pfkfb4/1077, pfkfb4/428 and pfkfb4/
166). We need to point out that all these constructs contain
21 nucleotides at their 3 0 termini from position +1 to 4 nucle-
otides upstream to the ATG. We also generated a 3 0 deleted
construct pfkfb4/428D (166). All these fragments, see sche-
ma in Fig. 6A, were transiently transfected into GC-1spg cellFig. 5. Schematic representation of 5 0-ﬂanking region of human pfkfb4 g
nucleotides upstream from the ATG codon) are numbered in the upper pa
transcription factor binding sites are indicated.line. The luciferase normalized values for the pfkfb4 constructs
were signiﬁcantly higher than the value for the construct
pfkfb4/428D (166) (Fig. 6B). These data suggest that at
least 141 bp of the 5 0-ﬂanking region from the transcription
start site are necessary for the testis-speciﬁc expression of the
human pfkfb4 gene. This region does not contain a TATA
box, although ETF sequences that are able to promote tran-
scription from TATA-less promoters [19] have been identiﬁed
(Fig. 5).
3.5. Regulation of pfkfb4 promoter
To study the eﬀect of serum, chemical hypoxia induced by
CoCl2, PDB and steroid hormones (b-estradiol and DHT)
on pfkfb4 gene expression, luciferase activity was measured
in cells transfected with the pfkfb4 promoter-luciferase gene
constructs (Fig. 7A and B). The eﬀects exerted by these treat-
ments are shown as fold increase in relative luciferase activity
(ratio of luciferase over b-galactosidase activity) over un-
treated cells.
In GC-1spg cells (Fig. 7A), FCS increased the luciferase
activity in all constructs assayed, having the greatest eﬀect in
the pfkfb4/166 construct. CoCl2 exhibited a signiﬁcant incre-
ment in luciferase activity in the constructs pfkfb4/428,
pfkfkb4/1077 and pfkfb4/1800, but no signiﬁcant eﬀect
was shown for pfkfb4/166. PDB did not show signiﬁcant ef-
fect in the luciferase activity of the pfkfb4 constructs.
To perform hormonal treatment, we use the TM-4 cell line
because it expresses estrogen and androgen receptors [20,21].
Serum increased the luciferase activity in all pfkfb4 constructs
between 2- and 3-fold (Fig. 7B). Hormonal treatment with
b-estradiol reduced luciferase activity in the constructs
pfkfb4/1077 and pfkfb4/1800, whereas DHT did not show
signiﬁcant eﬀects on the pfkb4 constructs.4. Discussion
The present results show that both pfkfb3 and pfkfb4
mRNAs are expressed in adult testis (Fig. 1), although onlyene. Bases relative to the transcription initiation site (located at 25
rt. Consensus TATA boxes, Sp-1, AP-2, ETF, HRE, GRE and SRE
Fig. 7. Response to serum, chemical hypoxia and PDB of luciferase
constructs transfected in GC-1spg cell line. (A) Luciferase reporter
activities of untreated cells versus cells treated with either 10% FCS,
200 lM CoCl2, or 20 nM PDB are shown. At least three experiments
were carried out with each construct. (B) Response to serum, b-
estradiol and DHT of luciferase constructs in TM-4 cell line.
Luciferase reporter activities of untreated cells versus cells treated
with either 7.5% serum (5% horse serum and 2.5% fetal calf serum),
109 M b-estradiol and DHT are shown. At least three experiments
were carried out with each construct. The results are expressed as fold
stimulation compared to normalized luciferase activity measured in
basal conditions, which was set to 1.0. Values reported in the ﬁgure
represent means ± S.E. Bars bearing (*) (P < 0.05), (**) (P < 0.01) and
(***) (P < 0.001) are statistically diﬀerent.
Fig. 6. Eﬀects of serial deletions on the promoter activity of human
pfkfb4 gene in GC-1spg cells. (A) Schematic representation of the
promoter constructs. (B) Luciferase values are normalized by cotrans-
fected b-galactosidase expression in GC-1spg lysates and are shown as
normalized luciferase activities. The experiments were performed in
triplicate at least in three independent experiments. Values reported in
the ﬁgure represent means ± S.E. Bars bearing (***) (P < 0.001) are
statistically diﬀerent.
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against tPFK-2 allowed us to determine that tPFK-2 is mainly
expressed in spermatogonia (GC-1spg) cells whereas Sertoli
cells (TM-4) express mainly uPFK-2.
We attempted to determine the size of the 5 0-UTR by rapid
ampliﬁcation of cDNA ends using minus strand cDNA prim-
ers and sequencing the PCR products. The human pfkfb4
transciption start site, refered as +1, was located at position
25 from the translation start codon. However, we could
not discard the existence of other potential initiation sites as
has been described in other testis speciﬁc genes [22,23]. The
minimal promoter unit of human pfkfb4 gene comprises the re-
gion between nucleotides 141 and +1. Two TATA like box
sequences (5 0 TTTAAA 3 0/5 0 TATAAA 3 0), similar to those
described in other genes [24], have been found at positions
1257 and 1744 nt. Several ETF sequences which are able
to drive transcription from TATA-less promoters [19] have
also been identiﬁed. Since the construct pfkfb4/166 has basal
activity similar to the largest construct, the putative TATA-
boxes present at pfkfb4/1800 might be non-functional and
the ETF sites are likely responsible for directing the expression
of pfkfb4 gene. When these 166 nucleotides are removed, the
basal expression of the resultant construct (pfkfb4/428D
(166)) is reduced signiﬁcantly. The presence of ETF se-
quences at positions 52, 71, 270 and 570 would explain
its importance in the transcriptional regulation of pfkfb4 gene.
GC-1spg cell line was used as a model system to evaluate the
modulation exerted by serum, CoCl2 and PDB on pfkfb4 pro-
moter, whereas the eﬀects exerted by b-estradiol and DHTwere studied on the TM-4 cell line because it contains estro-
gens and androgen receptors [20,21]. Serum increases lucifer-
ase activity in all constructs assayed, giving the greatest
response in the pfkfb4/166 construct. This promoter region
is GC-rich and several putative Sp-1 motifs can be identiﬁed
near the translational start site (Fig. 4). Sp1 can activate tran-
scription through a variety of mechanisms, functioning as both
a basal promoter element and upstream activator, depending
on promoter context [25]. Chemical hypoxia, which is pro-
duced by CoCl2 treatment, increases luciferase activity in the
constructs that contained at least 423 bp of the 5 0-ﬂanking se-
quence. HRE sequences present at positions 400, 492 and
1036 might be responsible for the induction of pfkfb4 gene
expression by hypoxia [11]. The same constructs were assayed
in TM-4 cell line. As in GC-1spg, serum increased luciferase
activity in all constructs. In contrast, b-estradiol reduced tran-
scription from pfkfb4/1077 and pfkfb4/1800 constructs.
This eﬀect could be due to the presence of GRE sequences at
positions 690, 1069, and 1605.
Taken together, all the data presented demonstrate a com-
plex genomic structure in the human pfkfb4 gene as well as
its regulation by multiple transcription factors. The expression
362 M. Go´mez et al. / FEBS Letters 579 (2005) 357–362of more than one isozyme in the diﬀerent cells of the same
tissue suggests that diﬀerent isozymes play modulatory roles
in diﬀerent physiological conditions or in response to speciﬁc
hormones. Further analyses have to be performed to determine
the speciﬁc contribution of each of these PFK-2 isozymes to
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